ImmunityBio's Anktiva wins conditional EMA approval, but faces stiff competition and financial risks. Click for why IBRX ...
Arbor Realty shrinks its balance sheet rather than deleveraging, which protects equity but mechanically compresses earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback